Welcome to LookChem.com Sign In|Join Free
  • or
N,N-BIS(2-CHLOROETHYL)-4-METHOXYANILINE, a member of the bis(chloroethyl)amines class, is a chemical compound characterized by its high toxicity and carcinogenic properties. It is primarily utilized as a chemical intermediate in the manufacturing processes of dyes and textiles. Due to its hazardous nature, it poses significant risks to human health and the environment, necessitating stringent safety measures during handling, storage, and disposal to mitigate potential adverse effects.

1448-52-8

Post Buying Request

1448-52-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1448-52-8 Usage

Uses

Used in Chemical Intermediates Industry:
N,N-BIS(2-CHLOROETHYL)-4-METHOXYANILINE is used as a chemical intermediate for the production of dyes and textiles, contributing to the coloration and quality of these products. Its role in this industry is crucial, despite the inherent risks associated with its use, due to its effectiveness in enhancing the characteristics of the final products.
Used in Safety and Environmental Management:
Given its high toxicity and carcinogenic nature, N,N-BIS(2-CHLOROETHYL)-4-METHOXYANILINE is also a key focus in the development and implementation of safety protocols and environmental management strategies. Its use necessitates the establishment of stringent safety measures to protect workers from exposure and to prevent environmental contamination, thereby ensuring the health and safety of both individuals and ecosystems.

Check Digit Verification of cas no

The CAS Registry Mumber 1448-52-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,4 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1448-52:
(6*1)+(5*4)+(4*4)+(3*8)+(2*5)+(1*2)=78
78 % 10 = 8
So 1448-52-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H15Cl2NO/c1-15-11-4-2-10(3-5-11)14(8-6-12)9-7-13/h2-5H,6-9H2,1H3

1448-52-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-bis(2-chloroethyl)-4-methoxyaniline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1448-52-8 SDS

1448-52-8Relevant academic research and scientific papers

Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies

Neelarapu, Raghupathi,Maignan, Jordany R.,Lichorowic, Cynthia L.,Monastyrskyi, Andrii,Mutka, Tina S.,LaCrue, Alexis N.,Blake, Lynn D.,Casandra, Debora,Mashkouri, Sherwin,Burrows, Jeremy N.,Willis, Paul A.,Kyle, Dennis E.,Manetsch, Roman

, p. 1450 - 1473 (2018/03/05)

Malaria deaths have been decreasing over the last 10-15 years, with global mortality rates having fallen by 47% since 2000. While the World Health Organization (WHO) recommends the use of artemisinin-based combination therapies (ACTs) to combat malaria, the emergence of artemisinin resistant strains underscores the need to develop new antimalarial drugs. Recent in vivo efficacy improvements of the historical antimalarial ICI 56,780 have been reported, however, with the poor solubility and rapid development of resistance, this compound requires further optimization. A series of piperazine-containing 4(1H)-quinolones with greatly enhanced solubility were developed utilizing structure-activity relationship (SAR) and structure-property relationship (SPR) studies. Furthermore, promising compounds were chosen for an in vivo scouting assay to narrow selection for testing in an in vivo Thompson test. Finally, two piperazine-containing 4(1H)-quinolones were curative in the conventional Thompson test and also displayed in vivo activity against the liver stages of the parasite.

ROS-Activated Compounds as Selective Anti-Cancer Therapeutics

-

Paragraph 0166, (2013/09/12)

Provided are compounds according to the following Formula I: The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer therapeutics for cancers associated with elevated ROS. Also provided are methods and pharmaceutical compositions for treating cancers associated with increased ROS.

A new disubstituted polyacetylene bearing DDTC moieties: Postfunctional synthetic strategy, selective and sensitive chemosensor towards mercury ions

Ou, Daxin,Qin, Jingui,Li, Zhen

, p. 5691 - 5698 (2013/01/15)

A new DDTC-functionalized disubstituted polyacetylene (P2) with strong green fluorescence was successfully synthesized by utilizing the postfunctional method. The polymer was soluble in common organic solvents, and its strong green fluorescence could be q

Synthesis and structure-analgesic activity relationships of a novel series of monospirocyclopiperazinium salts (MSPZ)

Lin, Song-Wen,Sun, Qi,Ge, Ze-Mei,Wang, Xin,Ye, Jia,Li, Run-Tao

supporting information; experimental part, p. 940 - 943 (2011/03/21)

A series of monospirocyclopiperazinium salts were designed and synthesized to search for a peripherally-acting analgesic drug with low side effects. Extensive SAR studies revealed that a suitable NR2R3 was critical for the analgesic activity, which might be beneficial to expose the cationic nitrogen to bind to the receptor, and possibly interact with the receptor via π-π interaction. Introduction of substituting group on the N4-phenyl ring could improve the activity, and the best position was the 4-position. Compound 14n showed more potent analgesic activity (63%, 20 μM/kg, sc) and holds promise for development as a mechanically new analgesic drug.

Hypoxia-Selective Antitumor Agents. 3. Relationships between Structure and Cytotoxicity against Cultured Tumor Cells for Substituted N,N-Bis(2-chloroethyl)anilines

Palmer, Brian D.,Wilson, William R.,Pullen, Susan M.,Denny, William A.

, p. 112 - 121 (2007/10/02)

A series of aniline mustards with a wide range of electron-donating and -withdrawing substituents in the 3- and 4-positions has been synthesized and evaluated for cytotoxicity in cell culture to examine the potential of using nitro group deactivated nitrogen mustards for the design of novel hypoxia-selective anticancer drugs (Denny, W.A.; Wilson, W.R.J.Med Chem. 1986, 29, 879).Hydrolytic half-lives in tissue culture media, determined by bioassay against a cell line (UV4) defective in the repair of DNA interstrand cross-links showed the expected dependence on the Hammett electronic parameter, ?, varying from 0.13 h for the 4-amino analogue to >100 h for analogues with strongly electron-withdrawing substituents.Cytotoxic potencies in aerobic UV4 cultures showed a similar dependence on ?.This dependence predicted that the 4-nitroaniline mustard would be 7200-fold less potent than its potential six-electron reduction product, the 4-amino compound, in growth inhibition assays using a 1-h drug exposure.The measured differential was much lower (225-fold) because of the instability of the latter compound, but a differential of 17500-fold was observed in the initial rate of killing by using a clonogenic assay.The potential for formation of reactive mustards by reduction to the amine or hydroxylamine was demonstrated by the 4-nitroso compound, which had an aerobic toxicity similar to that of the amine.Although these features confirmed the original rationale, the 3-nitro- and 4-nitroaniline mustards had only minimal hypoxic selectivity against UV cells.Toxicity to hypoxic cells appears to be limited by the low reduction potentials of these compounds and consequent lack of enzymatic nitroreduction.However, this study has demonstrated that nitro groups can be used to latentiate aromatic nitrogen mustards and indicates that examples with higher reduction potentials could provide useful hypoxia-selective therapeutic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1448-52-8